Zobrazeno 1 - 10
of 2 298
pro vyhledávání: '"Ooki A"'
Autor:
Kitagawa Y, Osumi H, Shinozaki E, Ota Y, Nakayama I, Suzuki T, Wakatsuki T, Ichimura T, Ogura M, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K
Publikováno v:
Cancer Management and Research, Vol Volume 11, Pp 5757-5764 (2019)
Yusuke Kitagawa, Hiroki Osumi, Eiji Shinozaki, Yumiko Ota, Izuma Nakayama, Takeshi Suzuki, Takeru Wakatsuki, Takashi Ichimura, Mariko Ogura, Akira Ooki, Daisuke Takahari, Mitsukuni Suenaga, Keisho Chin, Kensei YamaguchiDepartment of Gastroenterology,
Externí odkaz:
https://doaj.org/article/98990c583a004ae1a4a066ae64422bc6
Autor:
Takashi Oshima, Sachiko Yamamoto, Hisato Kawakami, Tomoki Makino, Akihito Kawazoe, Toshiki Masuishi, Takahiro Tsushima, Motohiro Hirao, Masahiro Tsuda, Kaori Hino, Noboru Yamamoto, Hiroki Hara, Shota Kaname, Daiko Matsuoka, Yohei Otake, Keisuke Yasuda, Takao Takase, Shuya Takashima, Taro Semba, Akira Ooki
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-7 (2024)
Abstract Background Esophageal cancer is one of the most common types of cancer in Japan. Herein, we report the efficacy and safety of E7389-LF plus the immune checkpoint inhibitor, nivolumab, from the esophageal cancer cohort of the phase 2 part of
Externí odkaz:
https://doaj.org/article/7dbdc5c5725f466f9c680a126d352047
Autor:
K. Shimozaki, K. Fukuda, A. Ooki, I. Nakayama, K. Yoshino, M. Tamba, S. Udagawa, S. Fukuoka, H. Osumi, T. Wakatsuki, D. Takahari, E. Shinozaki, M. Ogura, K. Chin, K. Yamaguchi
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 5, Iss , Pp 100072- (2024)
Background: This study aimed to evaluate the safety and efficacy of first-line nivolumab plus chemotherapy for real-world patients with human epidermal growth factor receptor 2 (HER2)-negative advanced gastric cancer (AGC). Materials and methods: Thi
Externí odkaz:
https://doaj.org/article/4ccb1cc6e20a47ef9fef2ed854e26a99
Autor:
Kubo, Norio, Suzuki, Shigemasa, Seki, Takahiro, Fukushima, Ryosuke, Furuke, Shunsaku, Yagi, Naoki, Ooki, Takashi, Aihara, Ryusuke, Araki, Kenichiro, Hosouchi, Yasuo, Shirabe, Ken
Publikováno v:
In HPB December 2024 26(12):1521-1527
Publikováno v:
In Journal of Marine Systems January 2025 247
Autor:
Shimozaki, K., Fukuda, K., Ooki, A., Nakayama, I., Yoshino, K., Tamba, M., Udagawa, S., Fukuoka, S., Osumi, H., Wakatsuki, T., Takahari, D., Shinozaki, E., Ogura, M., Chin, K., Yamaguchi, K.
Publikováno v:
In ESMO Gastrointestinal Oncology September 2024 5
Publikováno v:
In ESMO Open September 2024 9(9)
Autor:
Fukuda, K., Nakayama, I., Ooki, A., Kamiimabeppu, D., Shimozaki, K., Osumi, H., Fukuoka, S., Yoshino, K., Ogura, M., Wakatsuki, T., Chin, K., Shinozaki, E., Yamaguchi, K., Takahari, D.
Publikováno v:
In ESMO Gastrointestinal Oncology March 2024 3
Autor:
Koshiro Fukuda, Hiroki Osumi, Koichiro Yoshino, Izuma Nakayama, Shota Fukuoka, Mariko Ogura, Takeru Wakatsuki, Akira Ooki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Eiji Shinozaki
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Few studies have focused on the impact of single-organ pulmonary metastases on progression-free survival and overall survival in patients with metastatic colorectal cancer. Recognizing differences in prognosis and chemotherapeutic
Externí odkaz:
https://doaj.org/article/d13b8dce74d849dab9090169595d05c9
Autor:
K. Fukuda, I. Nakayama, A. Ooki, D. Kamiimabeppu, K. Shimozaki, H. Osumi, S. Fukuoka, K. Yoshino, M. Ogura, T. Wakatsuki, K. Chin, E. Shinozaki, K. Yamaguchi, D. Takahari
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 3, Iss , Pp 100046- (2024)
Background: Trifluridine (FTD)/tipiracil (TPI) is a standard salvage treatment for advanced gastric cancer (AGC). This study aimed to assess the efficacy and safety of FTD/TPI in heavily pretreated patients with AGC in clinical practice. Materials an
Externí odkaz:
https://doaj.org/article/d85962a7d1bd43329f3ad6af8511a373